
Your window to the world of the pharmaceutical industry - clinical trials and drug regulatory affairs
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 442 | Founded | 4 years ago | Last Issue | 7 days ago |
| Active | |||||

No drug (or vaccine) is “safe”…..not a single one. This is a fact that all credible clinicians and pharmacologists understand. It is indisputable.
In Australia, the law had to be amended to permit the government claim that the COVID-19 “va...
Only a small handful of politicians are prepared to tell you the truth about the origin of the man-made virus that caused the COVID-19 “pandemic”. See my Substack of 10 August 2023 HERE.
More details are coming to light about the bioweapon...
According to various Australian government No Jab No Play/Pay policies currently in force, parents are punished by preventing young children from attending childcare and important Family Tax Benefit support benefits are withheld if young ch...
It is reported that Shane’s Son now suspects his Dad may have died due to the Covid-19 vaccine.
I suspected this was the case immediately when I heard the sad news because the report of Shane Warnes’s death had all the classic hallmarks of...
Despite repeated Therapeutic Goods Administration (TGA) claims, we now know the experimental gene-based Covid-19 “vaccines” were not safe and effective. The massive amount of world-wide data generated clearly supports the withdrawal of thes...
Subscribers, engagement, traffic and sponsorship for Phillip Altman BPharm(Hons), MSc, PhD.
| Subscribers | Engagement | 83 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #66 |
The writers behind this newsletter.
Pharmacologist - Clinical Trial and Drug Regulatory Affairs senior industry pharmaceutical consultant in drug research and regulatory approval with more than 40 years experience. BPharm(Hons), MSc, PhD
You can find recent issues that have been published by Phillip Altman BPharm(Hons), MSc, PhD on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Phillip Altman BPharm(Hons), MSc, PhD, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Phillip Altman BPharm(Hons), MSc, PhD as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Phillip Altman BPharm(Hons), MSc, PhD using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Phillip Altman BPharm(Hons), MSc, PhD. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.